emerging tech investing DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference
emerging tech investing DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation
emerging tech investing DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress
emerging tech investing DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence Scientist to Accelerate our Innovation in Healthcare
emerging tech investing Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital
emerging tech investing Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital
emerging tech investing DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
emerging tech investing DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital
emerging tech investing DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors
emerging tech investing DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025
emerging tech investing Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA
Questcorp Mining and Riverside Resources Commence Phase 2 Exploration Program at the La Union Project, Sonora, Mexico
Alvopetro Announces Additional Firm Gas Sales, Updated Natural Gas Pricing & Q1 2026 Record Production
Drilling Resumes on Berrigan Zinc, Gold, Silver Property under Option from Chibougamau Independent Mines
